GB2363982A - Tamper-proof capsules - Google Patents

Tamper-proof capsules Download PDF

Info

Publication number
GB2363982A
GB2363982A GB0015523A GB0015523A GB2363982A GB 2363982 A GB2363982 A GB 2363982A GB 0015523 A GB0015523 A GB 0015523A GB 0015523 A GB0015523 A GB 0015523A GB 2363982 A GB2363982 A GB 2363982A
Authority
GB
United Kingdom
Prior art keywords
capsule
indicator
tamper
evident
active principle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0015523A
Other versions
GB0015523D0 (en
Inventor
Victor Morrison Young
James Savage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MW Encap Ltd
Original Assignee
MW Encap Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MW Encap Ltd filed Critical MW Encap Ltd
Priority to GB0015523A priority Critical patent/GB2363982A/en
Publication of GB0015523D0 publication Critical patent/GB0015523D0/en
Priority to PCT/GB2001/002825 priority patent/WO2002000206A2/en
Priority to AU66166/01A priority patent/AU6616601A/en
Publication of GB2363982A publication Critical patent/GB2363982A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Cosmetics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

A tamper-evident capsule system (1) comprising an inner capsule (2) containing an active principle (3) and encapsulated within an outer capsule (4) at least partially filled with at least a tamper evident indicator (5).

Description

2363982 TAMPER-EVIDENT CAPSULE SYSTEM
DESCRIPTION
This invention relates to a tamper-evident capsule system for the administration of at least one active principle in single or multiple therapy(ies).
Tampering with pharmaceutical products or other active principles encapsulated in two-piece capsules, has become of increasing concern.
Incidents, such as that in the United States of America where an individual adulterated capsules with cyanide resulting in the untimely death of several people, have resulted in agencies, such as the Federal Drug Administration, bringing out legislation requiring two-piece capsules to be banded as part of a tamper-evident system As a consequence of this legislation, all prescription capsules in the United States of America are required to be tamper-evident and from the end of 1999, it has been a requirement for all US OTC two-piece capsules to be banded for tamperevidence Companies in Europe are now using similar means for the same purpose.
A major disadvantage associated with a banded two-piece capsule is that it will only show tamper-evidence if it has been split or separated Small holes, such as those which can be caused by a hypodermic needle, leave little or no trace of the integrity of the capsule having been breached.
With hard capsules made of, say, hard gelatin, containing particulate material, a puncture hole formed in that material by, say, a hypodermic syringe, is usually sufficiently small for the particulate material to be retained in the capsule As a consequence, tamper-evidence is not apparent.
Similarly, an associated blister pack could be punctured without evidence of tampering.
Thus, it is an object of the present invention to provide a tamperevident capsule system which overcomes the disadvantages associated with known capsules and capsule systems discussed above, to provide evidence of tampering, particularly in relation to the contamination or other adulteration of the active principle contained therein.
Accordingly, a first aspect of the invention provides a tamper-evident capsule system comprising an inner capsule containing an active principle and encapsulated within an outer capsule at least partially filled with at least a tamper-evident indicator.
The inner capsule may be made of any suitable material, such as gelatin with or without a plasticiser, whilst the outer capsule is preferably made of hard gelatin or any other suitable material.
The indicator may be in any suitable form, as long as it is capable of being released from the outer capsule when the integrity thereof is breached.
A preferred indicator may be in the form of a liquid, more preferably of low viscosity, for example an oil, to provide tamper-evidence by visible means and/or smell.
However, any other suitable form of indicator may be employed, for example, a gas which, again, may provide tamper-evidence by visible means,
such as colour, and/or smell.
Also, the indicator may be selected to provide a secondary indication of tamper-evidence, for example, by smell, colour change, phase change or any combination thereof Further, the indicator may be coloured or colourless, as long as detection of its leakage from the outer capsule when the integrity thereof is breached, is maximised.
Types of tamper-evident indicator other than those mentioned above may be used, for example, semi-solid, solid and/or gelatinous materials.
The outer capsule is preferably of two-part form and sealed by banding or any other suitable method, whilst the inner capsule containing the active principle may also be in two-piece form, again sealed by banding, with the active principle being particulate, liquid, semi-liquid, solid or semisolid.
Further, the outer capsule may also contain, in addition to the tamperevident indicator, an active principle or other material The contents of the inner capsule may also include a colourant or other modifier, such as a p H indicator, capable of reacting with the indicator contained in the outer capsule when, say, the integrity of the inner capsule is breached.
The inner and outer capsules may be made from the same or different materials and one or both may be transparent Where the outer capsule is transparent, changes to the indicator contained therein and/or the inner capsule would be more obvious than having the outer capsule opaque Also, with a transparent outer capsule, the inner capsule could be readily identifiable by its colour markings and/or printing or any other identifying marks.
One or both of the inner and outer capsules may also be coated in known manner or uncoated, as required, and the system could comprise more than one inner capsule for, say, multi-therapy purposes.
Packaging, such as a blister pack could be used in addition to the innovative system discussed above as the integrity of such packaging could also be breached by, for example, a hypodermic syringe, with the outer capsule providing evidence of tampering.
A second aspect of the invention provides a method of rendering tamper-evident at least one capsule containing an active principle, which method comprises encapsulating the capsule(s) within an outer capsule containing a tamper-evident indicator.
The preferred characteristics of the outer capsule and/or tamper- evident indicator may be the same or similar to the preferences described above in relation to the first aspect of the invention.
In order that the various aspects of the invention may be more fully understood, a preferred embodiment in accordance therewith will now be described by way of example and with reference to the accompanying Figure which is a sectional view of a tamper-evident capsule system with an inner, soft gelatine capsule and an outer, hard gelatine capsule.
Referring now to the Figure, a tamper-evident capsule system, indicated generally at 1, comprises an inner one-piece, soft gelatine capsule 2 containing an active principle 3.
The inner capsule 2 and its contents of active principle 3 are encapsulated within an outer two-piece, hard gelatine capsule 4 at least partially filled with a tamper-evident indicator 5 which is of any suitable material capable of being released from the outer capsule 4 when the integrity of the latter is breached, for instance, by being punctured by a hypodermic needle.
The outer capsule 4 is banded at 6 in a conventional manner.
The inner capsule 2 is made of any suitable material, in this particular case, plasticised gelatin, whilst the outer capsule 4 is made of a hard material, for example, non-plasticised gelatin, as is conventional in the art.
Thus, by encapsulating the inner capsule 2 and its contents 3 in the form of an active principle, within the outer capsule 4 filled, at least partially, with at least a tamper-evident indicator 5, there is provided a tamper- evident capsule system 1 which is capable of evidencing tampering, for example, by attempting to adulterate the contents thereof by injection of a hazardous material into the system 1 by, for example, use of a hypodermic syringe.
As discussed above, the indicator 5 is a coloured liquid, such as a low viscosity oil However, it may take any other suitable form and may provide evidence of tampering by visual means, by smell or by a combination thereof Also, and in a modification of the capsule system 1 described above with reference to the drawing, a liquid active principle may be included with the indicator 5 in the outer capsule 4.
A further advantage of the present invention is that the outer capsule 4, and to a certain extent its contents 5, provides an additional layer of protection for the inner capsule 2 and its active principle contents 3.

Claims (1)

1 A tamper-evident capsule system comprising an inner capsule containing an active principle and encapsulated within an outer capsule at least partially filled with at least a tamper-evident indicator.
2 A system according to claim 1, wherein the inner capsule is made of gelatin with or without a plasticiser.
1 o 3 A system according to claim 1 or 2, wherein the outer capsule is made of hard gelatin.
4 A system according to claim 1, 2 or 3, wherein the indicator is in the form of a liquid, preferably of low viscosity.
A system according to claim 4, wherein the indicator is an oil.
6 A system according to claim 1, 2 or 3, wherein the indicator is a gas.
7 A system according to claim 1, 2 or 3, wherein the indicator is a semisolid, solid and/or gelatinous material.
8 A system according to any preceding claim, wherein the indicator is arranged to provide tamper-evidence by visible means, such as colour, and/or smell.
9 A system according to any preceding claim, wherein the indicator is selected to provide a secondary indication of tamper-evidence, for example, by smell, colour change, phase change or any combination thereof A system according to any preceding claim, wherein the indicator is coloured or colourless.
11 A system according to any preceding claim, wherein the outer capsule is of two-part form, preferably sealed by banding.
12 A system according to any preceding claim, wherein the active principle is particulate, liquid, semi-liquid, solid or semi-solid.
1 o 13 A system according to any preceding claim, wherein the outer capsule also contains, in addition to the tamper-evident indicator, an active principle or other material.
14 A system according to any preceding claim, wherein the contents of i 5 the inner capsule include a colourant or other modifier, such as a p H indicator, capable of reacting with the indicator contained in the outer capsule.
A system according to any preceding claim, wherein the inner and outer capsules are made of the same material.
16 A system according to any of claims 1 to 14, wherein the inner and outer capsules are made of different materials.
17 A system according to any preceding claim, wherein one or both of the inner and outer capsules is or are transparent.
18 A system according to any preceding claim, wherein one or both of the inner and outer capsules is or are coated.
19 A system according to any preceding claim, comprising more than one inner capsule.
A system according to any preceding claim, including outer packaging, preferably in the form of a blister pack.
21 A tamper-evident capsule system substantially as hereinbefore described with reference to the accompanying drawing.
22 A method of rendering tamper-evident at least one capsule containing an active principle, which method comprises encapsulating the capsule(s) with 1 o an outer capsule containing a tamper-evident indicator.
23 A method according to claim 22, wherein the inner capsule is made of gelatin with or without a plasticiser.
24 A method according to claim 22 or 23, wherein the outer capsule is made of hard gelatin.
A method according to claim 22, 23 or 24, wherein the indicator is provided in the form of a liquid, preferably of low viscosity.
26 A method according to claim 25, wherein the indictor is provided as an oil.
27 A method according to claim 22, 23 or 24, wherein the indicator is provided as a gas.
28 A method according to claim 22, 23 or 24, wherein the indicator is provided as a semi-solid, solid and/or gelatinous material.
29 A method according to any of claims 22 to 28, wherein the indicator provides tamper-evidence means, such as colour, and/or smell.
A method according to any of claims 22 to 29, wherein the indicator provides a secondary indication of tamper-evidence, for example, by smell,
colour change, phase change or any combination thereof 31 A method according to any of claims 22 to 30, wherein the indicator is coloured or colourless.
32 A method according to any of claims 22 to 31, wherein the outer capsule is provided in two-part form, preferably sealed by banding.
33 A method according to any of claims 22 to 32, wherein the active principle is provided as a particulate, liquid, semi-liquid, solid or semi-solid.
34 A method according to any of claims 22 to 33, wherein the outer capsule also contains, in addition to the tamper-evident indicator, an active principle or other material.
A method according to any of claims 22 to 34, wherein the contents of the inner capsule are provided with a colourant or other modifier, such as a p H indicator, capable of reacting with the indicator contained in the outer capsule.
36 A method according to any of claims 22 to 35, wherein the inner and outer capsules are made of the same material.
37 A method according to any of claims 22 to 35, wherein the inner and outer capsules are made of different materials.
38 A method according to any of claims 22 to 37, wherein one or both of the inner and outer capsules is or are transparent.
10- 39 A method according to any of claims 22 to 38, wherein one or both of the inner and outer capsules is or are coated.
A method according to any of claims 22 to 39, comprising more than one inner capsule.
41 A method according to any of claims 22 to 40, wherein tamper-evident rendered capsule is included in outer packaging, preferably in the form of a blister pack.
42 A method of rendering tamper-evident at least one capsule containing an active principle substantially as hereinbefore described with reference to the accompanying drawing.
GB0015523A 2000-06-26 2000-06-26 Tamper-proof capsules Withdrawn GB2363982A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0015523A GB2363982A (en) 2000-06-26 2000-06-26 Tamper-proof capsules
PCT/GB2001/002825 WO2002000206A2 (en) 2000-06-26 2001-06-26 Tamper-evident capsule system
AU66166/01A AU6616601A (en) 2000-06-26 2001-06-26 Tamper-evident capsule system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0015523A GB2363982A (en) 2000-06-26 2000-06-26 Tamper-proof capsules

Publications (2)

Publication Number Publication Date
GB0015523D0 GB0015523D0 (en) 2000-08-16
GB2363982A true GB2363982A (en) 2002-01-16

Family

ID=9894335

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0015523A Withdrawn GB2363982A (en) 2000-06-26 2000-06-26 Tamper-proof capsules

Country Status (3)

Country Link
AU (1) AU6616601A (en)
GB (1) GB2363982A (en)
WO (1) WO2002000206A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2365336B (en) * 2000-07-20 2004-05-19 Mw Encap Ltd Delivery device

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002322344C1 (en) 2001-06-27 2006-02-16 Smithkline Beecham Corporation Fluoropyrrolidines as dipeptidyl peptidase inhibitors
GB0303113D0 (en) * 2003-02-12 2003-03-19 Mw Encap Ltd Encapsulated flavouring for foods
US7682696B2 (en) 2004-09-13 2010-03-23 Sabic Innovative Plastics Ip B.V. Medical article and method of making and using the same
GB0506982D0 (en) * 2005-04-06 2005-05-11 Mw Encap Ltd Abuse resistant capsules
US20110171281A1 (en) * 2010-01-14 2011-07-14 Karl Wei Cao Soft capsule composition and method of use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3702653A (en) * 1970-09-14 1972-11-14 Parke Davis & Co Package means
US4434893A (en) * 1983-01-14 1984-03-06 Gordon Barlow Design Tamper evident packaging
US4883182A (en) * 1985-05-31 1989-11-28 Hughes Raymond J Tamper evident capsule and insert device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1815902A (en) * 1927-07-16 1931-07-28 Nat Aniline & Chem Co Inc Device for administering medicaments
FR1454013A (en) * 1965-08-18 1966-07-22 Pluripharm Presentation of two combined medicinal products
DE2729068A1 (en) * 1977-06-28 1979-01-11 Rainer Dr Med Liedtke Releasing incompatible pharmaceuticals from capsules - by including a second capsule inside the first
FR2524311A1 (en) * 1982-04-05 1983-10-07 Azalbert Gilles Multi:effect medical capsule with compartments contg. different medica - which are ingested simultaneously for programmed release to treat patient
US5624681A (en) * 1995-04-26 1997-04-29 R. P. Scherer Corporation Tamper evident pharmaceutical dosage form
JP3667045B2 (en) * 1997-09-10 2005-07-06 森下仁丹株式会社 Multiple soft capsules for removing bad breath and method for producing the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3702653A (en) * 1970-09-14 1972-11-14 Parke Davis & Co Package means
US4434893A (en) * 1983-01-14 1984-03-06 Gordon Barlow Design Tamper evident packaging
US4883182A (en) * 1985-05-31 1989-11-28 Hughes Raymond J Tamper evident capsule and insert device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2365336B (en) * 2000-07-20 2004-05-19 Mw Encap Ltd Delivery device

Also Published As

Publication number Publication date
WO2002000206A2 (en) 2002-01-03
WO2002000206A3 (en) 2002-04-11
GB0015523D0 (en) 2000-08-16
AU6616601A (en) 2002-01-08

Similar Documents

Publication Publication Date Title
US4986429A (en) Color indicating tamper-proof seal
US4511052A (en) Container seal with tamper indicator
US4813541A (en) Tamperproof package and method
US4867326A (en) Child resistant cap and tube assembly
EP0109592A2 (en) Tamper-indicating capped container
US5779364A (en) Temperature sensitive device for medicine containers
US3899295A (en) Integrity indicator
JP6467720B2 (en) Container cap
AU757824B2 (en) Tamper evident syringe assembly
US5228573A (en) Pharmaceutical capsule and method of making
JPH04505718A (en) mixing device
KR20020084819A (en) A tamper evident closure
MX2007014336A (en) Packaging system and method of alerting a practitioner.
EP0105971A2 (en) Receptacle tampering sensor and indicator and method therefor
US4418827A (en) Tamper-alerting device for vials and syringes
US4793503A (en) Container closure with rupturable tamper disk
GB2363982A (en) Tamper-proof capsules
GB2552167A (en) Time temerature indicator label
AU2016212232B9 (en) Container closure systems
US20050258129A1 (en) Tamper-proof closure/seal for containers, particularly wine bottles
GB2243825A (en) Sealing member and container sealed therewith
US8007883B2 (en) Container comprising a transparent cylindrical container wall
JP3126232U (en) Multi-chamber container
US20080184927A1 (en) Container cap for assuring quality
WO1989005761A1 (en) A method of verifying that a package is unbroken

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)